Protection against group A streptococcus by immunization with J8-diphtheria toxoid: Contribution of J8-and diphtheria toxoid-specific antibodies to protection

被引:153
作者
Batzloff, MR
Hayman, WA
Davies, MR
Zeng, M
Pruksakorn, S
Brandt, ER
Good, MF
机构
[1] Queensland Inst Med Res, Cooperat Res Ctr Vaccine Technol, Brisbane, Qld 4029, Australia
[2] Queensland Inst Med Res, Australian Ctr Int Trop Hlth & Nutr, Brisbane, Qld 4029, Australia
关键词
D O I
10.1086/374800
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A conformationally constrained, minimally conserved peptide from the M protein of group A streptococcus ( GAS) has been defined. It consists of 12 amino acids from the C-repeat region within a non - M protein helix-forming sequence and is referred to as "J8." Here, we investigate the immunogenicity of a J8-diphtheria toxoid (DT) conjugate adjuvanted with the human-compatible adjuvants, SBAS2 and alum, and demonstrate that it is capable of inducing opsonic antibodies and can protect outbred mice from virulent challenge. In a range of experiments, protection correlated with the titer of J8-specific antibodies and not with the induction of J8-specific T cells. However, DT-specific antibodies ( as well as J8-specific antibodies) were shown to stain the surface of fixed GAS and to be capable of opsonizing live organisms. DT may be an ideal carrier protein for J8 and other GAS peptides for GAS vaccines.
引用
收藏
页码:1598 / 1608
页数:11
相关论文
共 46 条
[1]   TYPE-SPECIFIC PROTECTIVE IMMUNITY EVOKED BY SYNTHETIC PEPTIDE OF STREPTOCOCCUS-PYOGENES M-PROTEIN [J].
BEACHEY, EH ;
SEYER, JM ;
DALE, JB ;
SIMPSON, WA ;
KANG, AH .
NATURE, 1981, 292 (5822) :457-459
[2]  
BESSEN D, 1990, J IMMUNOL, V145, P1251
[3]   INFLUENCE OF INTRANASAL IMMUNIZATION WITH SYNTHETIC PEPTIDES CORRESPONDING TO CONSERVED EPITOPES OF M-PROTEIN ON MUCOSAL COLONIZATION BY GROUP-A STREPTOCOCCI [J].
BESSEN, D ;
FISCHETTI, VA .
INFECTION AND IMMUNITY, 1988, 56 (10) :2666-2672
[4]   Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci [J].
Brandt, ER ;
Hayman, WA ;
Currie, B ;
Carapetis, J ;
Wood, Y ;
Jackson, DC ;
Cooper, J ;
Melrose, WD ;
Saul, AJ ;
Good, MF .
IMMUNOLOGY, 1996, 89 (03) :331-337
[5]   Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci [J].
Brandt, ER ;
Teh, T ;
Relf, WA ;
Hobb, RI ;
Good, MF .
INFECTION AND IMMUNITY, 2000, 68 (12) :6587-6594
[6]   Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci [J].
Brandt, ER ;
Hayman, WA ;
Currie, B ;
Pruksakorn, S ;
Good, MF .
VACCINE, 1997, 15 (16) :1805-1812
[7]   New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population [J].
Brandt, ER ;
Sriprakash, KS ;
Hobb, RI ;
Hayman, WA ;
Zeng, WG ;
Batzloff, MR ;
Jackson, DC ;
Good, MF .
NATURE MEDICINE, 2000, 6 (04) :455-459
[8]  
BRONZE MS, 1992, J IMMUNOL, V148, P888
[9]   Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory [J].
Carapetis, JR ;
Wolff, DR ;
Currie, BJ .
MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (03) :146-149
[10]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631